This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

A Randomized, Clinical Trial of Oral Midazolam Versus Oral Ketamine for Sedation During Laceration Repair.

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2013 by Assaf-Harofeh Medical Center.
Recruitment status was:  Recruiting
Information provided by (Responsible Party):
Assaf-Harofeh Medical Center Identifier:
First received: July 17, 2013
Last updated: January 20, 2014
Last verified: August 2013

Sedation is often needed for young children undergoing minor procedures in the emergency department (ED). Oral midazolam is one of the most commonly used regimens for children undergoing laceration repair but its sedative efficacy was shown to be suboptimal. In only one randomized controlled study oral ketamine has been used successfully for procedural sedation for laceration repair. A recent study showed that the combination of oral midazolam and oral ketamine provided deeper sedation compared with oral midazolam alone. However children treated wuth the combination of midazolam and ketamine required longer recovery


Oral ketamine can provide superior sedation to oral midazolam in children requiring sedation for laceration repair.

Condition Intervention Phase
Lacerations Drug: Midazolam - active comparator Drug: Experimental Arm: Ketamine Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Randomized, Clinical Trial of Oral Midazolam Versus Oral Ketamine for Sedation During Laceration Repair.

Resource links provided by NLM:

Further study details as provided by Assaf-Harofeh Medical Center:

Primary Outcome Measures:
  • Pain score: Visual analog score (VAS)- by a parent [ Time Frame: During the procedure - up to 1 hour ]
    A parent will assess the child's pain on a Visual analog scale

  • Number of patients requiring IV sedation [ Time Frame: During the procedure - up to 1 hour ]
    patients who fail to achieve University of Michigan Sedation Scale (UMSS) of two or higher will be switched to IV sedation

Secondary Outcome Measures:
  • UMSS - by ED physician [ Time Frame: During the procedure - up to 1 hour ]
  • • VAS by nurse [ Time Frame: During the procedure - up to 1 hour ]
  • Time to reach UMSS > 2 [ Time Frame: up to 1 hour ]
  • • Procedure time [ Time Frame: During the procedure - up to 1 hour ]
  • • Time from procedure to full recovery [ Time Frame: While in the ED - estimated time around 2 hours ]
  • The occurrence of adverse effects during the ED stay [ Time Frame: While in the ED - estimated time around 2 hours ]

    Significant adverse effects are defined as

    1. Oxygen desaturation <92% or hypoventilation requiering ventilatory support
    2. Need for hemodynamic support
    3. Anaphylaxis
    4. Seizures
    5. Any adverse effects requiring patient admission

  • • Patients and parents satisfaction assessed on VAS [ Time Frame: While in the ED - estimated time around 2 hours ]

Estimated Enrollment: 60
Study Start Date: August 2013
Estimated Study Completion Date: July 2014
Estimated Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Ketamine
Oral ketamine
Drug: Experimental Arm: Ketamine
Oral Ketamine 5mg/kg Single dose
Other Name: Ketalar
Active Comparator: Midazolam
Oral Midazolam
Drug: Midazolam - active comparator
Oral midazolam - 0.7mg/kg single dose
Other Name: Dormicum


Ages Eligible for Study:   1 Year to 10 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

• Any child with laceration requiring sedation

Exclusion Criteria:

  • Major trauma
  • Closed head injury associated with loss of consciousness
  • Abnormal neurologic examination in a previously normal child
  • Significant developmental delay or baseline neurological deficit
  • A patient with seizures
  • Elevated intra-cranial pressure
  • Hypersensitivity to midazolam or ketamine
  • Hypertension
  • Hyperthyroidism or a patient receiving thyroid replacement
  • alcohol intoxication or a history of alcohol abuse
  • Acute or chronic respiratory, cardiac, renal or hepatic abnormalities
  • Glaucoma
  • Known psychiatric disease
  • American Society of Anesthesiologists (ASA) score of more than 2
  • Informed consent cannot be obtained from legal guardian
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01925898

Contact: Eran Kozer, MD 972-8-9779916

Assaf Harofeh MC Recruiting
Be'er Ya`aqov, Israel
Contact: Orit Rubinstein, MD    972-8-9779916   
Sub-Investigator: Orit Rubinstein, MD         
Sponsors and Collaborators
Assaf-Harofeh Medical Center
  More Information

Responsible Party: Assaf-Harofeh Medical Center Identifier: NCT01925898     History of Changes
Other Study ID Numbers: 87/13
Study First Received: July 17, 2013
Last Updated: January 20, 2014

Keywords provided by Assaf-Harofeh Medical Center:

Additional relevant MeSH terms:
Wounds and Injuries
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Anesthetics, Dissociative
Anesthetics, Intravenous
Anesthetics, General
Central Nervous System Depressants
Excitatory Amino Acid Antagonists
Excitatory Amino Acid Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Adjuvants, Anesthesia
Hypnotics and Sedatives
Anti-Anxiety Agents
Tranquilizing Agents
Psychotropic Drugs
GABA Modulators
GABA Agents processed this record on August 18, 2017